Théa Open Innovation
Clermont-Ferrandtheaopeninnovation.com
Overview
Théa Open Innovation is the strategic venture and licensing unit of Laboratoires Théa, focused on investing in and partnering with companies and research institutions to develop innovative products in ophthalmology.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Link Biologics | Sep 2023 | Strategic | Lead |
| Galimedix Therapeutics | Mar 2023 | Strategic | Lead |
| Coave Therapeutics | Jul 2021 | Series B | Co-investor |
| Ripple Therapeutics | Dec 2020 | Series A | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
